S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synergy Pharmaceuticals Reports Third Quarter 2014 Financial Results|
|Synergy Pharmaceuticals Announces Positive Results of SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation|
|Synergy Pharmaceuticals Inc. Announces Issuance of $200 Million of 7.50% Convertible Senior Notes|
|Synergy Pharmaceuticals Inc. Announces Pricing of Private Offering of $175 Million of 7.50% Convertible Senior Notes|
|Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation|
|Synergy Pharmaceuticals Inc. Announces Full Exercise of Over-Allotment Option|
|Synergy Pharmaceuticals Inc. Announces Private Offering of Convertible Senior Notes|
|Synergy Pharmaceuticals Completes Patient Enrollment for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation|
|Synergy Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference|
|ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board|
Click above to view more mutual fund data and stats for sgyp - Synergy Pharmaceuticals Inc.